Hui Miao
Director/Miembro de la Junta en Beijing Zhendong Langdi Pharmaceutical Co., Ltd. .
Cargos activos de Hui Miao
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Beijing Zhendong Langdi Pharmaceutical Co., Ltd.
Beijing Zhendong Langdi Pharmaceutical Co., Ltd. Pharmaceuticals: OtherHealth Technology Part of Fountainvest Partners (Asia) Ltd., Beijing Zhendong Langdi Pharmaceutical Co., Ltd. manufactures medicinal chemicals and botanical products. The company is based in Beijing, China. Beijing Zhendong Langdi Pharmaceutical Co. was acquired by Shanghai Fanglang Enterprise Management Co. Ltd. from Shanxi Zhendong Pharmaceutical Co., Ltd. on October 28, 2021 for $895.09 million. The Chinese company was founded in 2003. | Director/Miembro de la Junta | - | - |
Historial de carrera de Hui Miao
Antiguos cargos conocidos de Hui Miao.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. | Director/Miembro de la Junta | 17/10/2022 | 09/04/2024 |
Director Ejecutivo | 01/07/2022 | 09/04/2024 | |
Corporate Officer/Principal | 01/07/2022 | 23/09/2022 | |
Presidente | 23/09/2022 | 09/04/2024 |
Formación de Hui Miao.
Renmin University of China | Undergraduate Degree |
Estadísticas
Internacional
China | 4 |
Operativa
Director/Board Member | 2 |
Chief Executive Officer | 1 |
Corporate Officer/Principal | 1 |
Sectorial
Health Technology | 3 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. | Health Technology |
Empresas privadas | 1 |
---|---|
Beijing Zhendong Langdi Pharmaceutical Co., Ltd.
Beijing Zhendong Langdi Pharmaceutical Co., Ltd. Pharmaceuticals: OtherHealth Technology Part of Fountainvest Partners (Asia) Ltd., Beijing Zhendong Langdi Pharmaceutical Co., Ltd. manufactures medicinal chemicals and botanical products. The company is based in Beijing, China. Beijing Zhendong Langdi Pharmaceutical Co. was acquired by Shanghai Fanglang Enterprise Management Co. Ltd. from Shanxi Zhendong Pharmaceutical Co., Ltd. on October 28, 2021 for $895.09 million. The Chinese company was founded in 2003. | Health Technology |
- Bolsa de valores
- Insiders
- Hui Miao
- Experiencia